| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cyclosporin A binding | PPIAL4C PPIAL4E PPIAL4D PPIAL4H PPIAL4A PPIAL4G PPIA PPIAL4F | 4.39e-14 | 24 | 83 | 8 | GO:0016018 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | PPIAL4C PPIAL4E PPIAL4D PPIAL4H PPIAL4A PPIAL4G PPIA PPIAL4F | 2.94e-11 | 50 | 83 | 8 | GO:0003755 |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | PPIAL4C PPIAL4E PPIAL4D PPIAL4H PPIAL4A PPIAL4G PPIA PPIAL4F | 4.80e-11 | 53 | 83 | 8 | GO:0016859 |
| GeneOntologyMolecularFunction | isomerase activity | PPIAL4C PPIAL4E PPIAL4D PPIAL4H SREBF2 PPIAL4A PPIAL4G PPIA PPIAL4F | 1.04e-07 | 192 | 83 | 9 | GO:0016853 |
| GeneOntologyMolecularFunction | amide binding | CACNA1B PPIAL4C PPIAL4E PPIAL4D PPIAL4H PPIAL4A PNPLA3 PPIAL4G PPIA PPIAL4F | 4.52e-07 | 299 | 83 | 10 | GO:0033218 |
| GeneOntologyMolecularFunction | poly(A) RNA polymerase activity | 1.48e-05 | 12 | 83 | 3 | GO:1990817 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | TYK2 TLK2 JAK3 PARP11 POLR3B NEK10 GRK4 SYK PAPOLB TRRAP MAP4K4 TENT5B PTK6 PAPOLG | 2.97e-05 | 938 | 83 | 14 | GO:0016772 |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 3.96e-05 | 46 | 83 | 4 | GO:0004715 | |
| GeneOntologyMolecularFunction | mono-olein transacylation activity | 5.11e-05 | 3 | 83 | 2 | GO:0051264 | |
| GeneOntologyMolecularFunction | diolein transacylation activity | 5.11e-05 | 3 | 83 | 2 | GO:0051265 | |
| GeneOntologyMolecularFunction | adenylyltransferase activity | 2.86e-04 | 31 | 83 | 3 | GO:0070566 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 4.31e-04 | 152 | 83 | 5 | GO:0016779 | |
| GeneOntologyMolecularFunction | growth hormone receptor binding | 7.52e-04 | 10 | 83 | 2 | GO:0005131 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.50e-03 | 14 | 83 | 2 | GO:0008331 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | PPIAL4C PPIAL4E PPIAL4D PPIAL4H PPIAL4A PPIAL4G PPIA PPIAL4F | 1.76e-12 | 38 | 81 | 8 | GO:0000413 |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | PPIAL4C PPIAL4E PPIAL4D PPIAL4H PPIAL4A PPIAL4G PPIA PPIAL4F | 3.57e-11 | 54 | 81 | 8 | GO:0018208 |
| GeneOntologyBiologicalProcess | protein folding | PPIAL4C PPIAL4E PPIAL4D SACS PPIAL4H PPIAL4A PPIAL4G PPIA PPIAL4F | 5.21e-07 | 246 | 81 | 9 | GO:0006457 |
| GeneOntologyBiologicalProcess | regulation of thymocyte apoptotic process | 6.34e-05 | 20 | 81 | 3 | GO:0070243 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | TLK2 JAK3 PPIAL4C PPIAL4E PPIAL4D PPIAL4H SYK PPIAL4A PPIAL4G PPIA TP53 PTK6 PPIAL4F | 1.04e-04 | 976 | 81 | 13 | GO:0018193 |
| GeneOntologyBiologicalProcess | protein maturation | PPIAL4C PPIAL4E PPIAL4D SACS PPIAL4H TLL2 PPIAL4A PPIAL4G PPIA PPIAL4F | 1.52e-04 | 619 | 81 | 10 | GO:0051604 |
| GeneOntologyBiologicalProcess | thymocyte apoptotic process | 1.59e-04 | 27 | 81 | 3 | GO:0070242 | |
| Domain | Cyclophilin-type_PPIase_CS | 1.32e-10 | 19 | 80 | 6 | IPR020892 | |
| Domain | Cyclophilin-type_PPIase | 2.63e-10 | 21 | 80 | 6 | IPR024936 | |
| Domain | Cyclophilin-like_dom | 3.60e-10 | 22 | 80 | 6 | IPR029000 | |
| Domain | CSA_PPIASE_2 | 3.60e-10 | 22 | 80 | 6 | PS50072 | |
| Domain | Pro_isomerase | 3.60e-10 | 22 | 80 | 6 | PF00160 | |
| Domain | - | 3.60e-10 | 22 | 80 | 6 | 2.40.100.10 | |
| Domain | Cyclophilin-type_PPIase_dom | 3.60e-10 | 22 | 80 | 6 | IPR002130 | |
| Domain | CSA_PPIASE_1 | 3.60e-10 | 22 | 80 | 6 | PS00170 | |
| Domain | - | 5.42e-05 | 3 | 80 | 2 | 3.30.70.590 | |
| Domain | PAP_central | 5.42e-05 | 3 | 80 | 2 | PF04928 | |
| Domain | PAP_RNA-bind | 5.42e-05 | 3 | 80 | 2 | PF04926 | |
| Domain | PolA_pol_cen_dom | 5.42e-05 | 3 | 80 | 2 | IPR007012 | |
| Domain | PolA_pol_RNA-bd_dom | 5.42e-05 | 3 | 80 | 2 | IPR007010 | |
| Domain | ROR_rcpt | 5.42e-05 | 3 | 80 | 2 | IPR003079 | |
| Domain | PolyA_polymerase | 5.42e-05 | 3 | 80 | 2 | IPR014492 | |
| Domain | NuclTrfase_I_C | 5.42e-05 | 3 | 80 | 2 | IPR011068 | |
| Domain | PROTEIN_KINASE_TYR | 6.02e-05 | 97 | 80 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 6.02e-05 | 97 | 80 | 5 | IPR008266 | |
| Domain | Tyr_kinase_non-rcpt_Jak/Tyk2 | 1.08e-04 | 4 | 80 | 2 | IPR016251 | |
| Domain | PLPL | 1.80e-04 | 5 | 80 | 2 | IPR033562 | |
| Domain | Protein_kinase_ATP_BS | 2.17e-04 | 379 | 80 | 8 | IPR017441 | |
| Domain | EGF_CA | 5.08e-04 | 86 | 80 | 4 | PF07645 | |
| Domain | Kinase-like_dom | 5.08e-04 | 542 | 80 | 9 | IPR011009 | |
| Domain | TyrKc | 5.54e-04 | 88 | 80 | 4 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 5.54e-04 | 88 | 80 | 4 | IPR020635 | |
| Domain | Patatin/PLipase_A2-rel | 6.40e-04 | 9 | 80 | 2 | IPR002641 | |
| Domain | Patatin | 6.40e-04 | 9 | 80 | 2 | PF01734 | |
| Domain | PNPLA | 6.40e-04 | 9 | 80 | 2 | PS51635 | |
| Domain | PROTEIN_KINASE_ATP | 7.72e-04 | 459 | 80 | 8 | PS00107 | |
| Domain | VDCCAlpha1 | 7.97e-04 | 10 | 80 | 2 | IPR002077 | |
| Domain | EGF_Ca-bd_CS | 7.99e-04 | 97 | 80 | 4 | IPR018097 | |
| Domain | EGF_CA | 8.63e-04 | 99 | 80 | 4 | PS01187 | |
| Domain | NTP_transf_2 | 9.72e-04 | 11 | 80 | 2 | PF01909 | |
| Domain | Polymerase_NTP_transf_dom | 9.72e-04 | 11 | 80 | 2 | IPR002934 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.11e-03 | 106 | 80 | 4 | IPR000152 | |
| Domain | Prot_kinase_dom | 1.16e-03 | 489 | 80 | 8 | IPR000719 | |
| Domain | CUB | 1.21e-03 | 49 | 80 | 3 | PF00431 | |
| Domain | DNAJ_1 | 1.21e-03 | 49 | 80 | 3 | PS00636 | |
| Domain | DNAJ_2 | 1.21e-03 | 49 | 80 | 3 | PS50076 | |
| Domain | DnaJ | 1.21e-03 | 49 | 80 | 3 | SM00271 | |
| Domain | - | 1.21e-03 | 49 | 80 | 3 | 1.10.287.110 | |
| Domain | PROTEIN_KINASE_DOM | 1.22e-03 | 493 | 80 | 8 | PS50011 | |
| Domain | SH2 | 1.28e-03 | 110 | 80 | 4 | SM00252 | |
| Domain | CUB | 1.28e-03 | 50 | 80 | 3 | SM00042 | |
| Domain | SH2 | 1.32e-03 | 111 | 80 | 4 | PS50001 | |
| Domain | DnaJ_domain | 1.36e-03 | 51 | 80 | 3 | IPR001623 | |
| Domain | SH2 | 1.37e-03 | 112 | 80 | 4 | IPR000980 | |
| Domain | - | 1.37e-03 | 112 | 80 | 4 | 3.30.505.10 | |
| Domain | - | 1.44e-03 | 52 | 80 | 3 | 2.60.120.290 | |
| Domain | CUB | 1.52e-03 | 53 | 80 | 3 | PS01180 | |
| Domain | EGF_CA | 1.87e-03 | 122 | 80 | 4 | SM00179 | |
| Domain | CUB_dom | 1.87e-03 | 57 | 80 | 3 | IPR000859 | |
| Domain | Channel_four-helix_dom | 1.87e-03 | 57 | 80 | 3 | IPR027359 | |
| Domain | - | 1.87e-03 | 57 | 80 | 3 | 1.20.120.350 | |
| Domain | EGF-like_Ca-bd_dom | 1.98e-03 | 124 | 80 | 4 | IPR001881 | |
| Domain | Pkinase_Tyr | 2.29e-03 | 129 | 80 | 4 | PF07714 | |
| Domain | Acyl_Trfase/lysoPLipase | 2.36e-03 | 17 | 80 | 2 | IPR016035 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 2.92e-03 | 138 | 80 | 4 | IPR001245 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 29307578 | ||
| Pubmed | Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia. | 5.76e-06 | 2 | 84 | 2 | 36191479 | |
| Pubmed | NEK10 tyrosine phosphorylates p53 and controls its transcriptional activity. | 5.76e-06 | 2 | 84 | 2 | 32561851 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 22133803 | ||
| Pubmed | Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides. | 5.76e-06 | 2 | 84 | 2 | 26082451 | |
| Pubmed | TDP-43 regulates cholesterol biosynthesis by inhibiting sterol regulatory element-binding protein 2. | 5.76e-06 | 2 | 84 | 2 | 35568729 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 20478313 | ||
| Pubmed | Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. | 5.76e-06 | 2 | 84 | 2 | 22265415 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 33083484 | ||
| Pubmed | ER, p53 and MIB-1 are significantly associated with malignant phyllodes tumor. | 5.76e-06 | 2 | 84 | 2 | 23442362 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 38844154 | ||
| Pubmed | 7.44e-06 | 16 | 84 | 3 | 19464057 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 34257081 | ||
| Pubmed | TDP-43 induces p53-mediated cell death of cortical progenitors and immature neurons. | 1.73e-05 | 3 | 84 | 2 | 29802307 | |
| Pubmed | Transcriptional regulation of the mdm2 oncogene by p53 requires TRRAP acetyltransferase complexes. | 1.73e-05 | 3 | 84 | 2 | 12138177 | |
| Pubmed | Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members. | 1.73e-05 | 3 | 84 | 2 | 16150821 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 26204652 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 26512780 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 25635878 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | RALY PARP11 POLR3B RTCA TRMT11 ANKRD17 CAT KLHL8 TRRAP MAP4K4 TP53 | 3.01e-05 | 1005 | 84 | 11 | 19615732 |
| Pubmed | Three distinct signalling responses by murine fibroblasts to genotoxic stress. | 3.45e-05 | 4 | 84 | 2 | 8918879 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 30977208 | ||
| Pubmed | Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade. | 3.45e-05 | 4 | 84 | 2 | 35236758 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 31253182 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 30709742 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 15364929 | ||
| Pubmed | Selective targeting p53WT lung cancer cells harboring homozygous p53 Arg72 by an inhibitor of CypA. | 3.45e-05 | 4 | 84 | 2 | 28394340 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 24843152 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 26676373 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 8491200 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALY TYK2 DNAJC13 FAM120A USP40 DAB1 SREBF2 ANKRD17 LRBA ZNF512 SNX9 TRRAP PTK6 | 5.68e-05 | 1489 | 84 | 13 | 28611215 |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 12897156 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 21878673 | ||
| Pubmed | A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma. | 5.74e-05 | 5 | 84 | 2 | 30955884 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 10531356 | ||
| Pubmed | TDP-43 mediates SREBF2-regulated gene expression required for oligodendrocyte myelination. | 5.74e-05 | 5 | 84 | 2 | 34347016 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 22288532 | ||
| Pubmed | Genetic variance in the adiponutrin gene family and childhood obesity. | 5.74e-05 | 5 | 84 | 2 | 19390624 | |
| Pubmed | 6.05e-05 | 87 | 84 | 4 | 29991678 | ||
| Pubmed | A quantitative protein interaction network for the ErbB receptors using protein microarrays. | 6.91e-05 | 90 | 84 | 4 | 16273093 | |
| Pubmed | The RNA binding protein RALY suppresses p53 activity and promotes lung tumorigenesis. | 8.59e-05 | 6 | 84 | 2 | 36952348 | |
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 14966198 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 30354839 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 25057888 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RALY TARDBP DNAJC13 POLR3B FAM120A RTCA MIB1 ANKRD17 CAT ZNF512 PPIA TRRAP | 9.72e-05 | 1353 | 84 | 12 | 29467282 |
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 29674694 | ||
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 28191885 | ||
| Pubmed | JAK signaling regulates germline cyst breakdown and primordial follicle formation in mice. | 1.20e-04 | 7 | 84 | 2 | 29242197 | |
| Pubmed | FUS, TARDBP, and SOD1 mutations in a Taiwanese cohort with familial ALS. | 1.20e-04 | 7 | 84 | 2 | 20472325 | |
| Pubmed | STAM2, a new member of the STAM family, binding to the Janus kinases. | 1.60e-04 | 8 | 84 | 2 | 10899310 | |
| Pubmed | 1.60e-04 | 8 | 84 | 2 | 28330839 | ||
| Pubmed | Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis. | 1.60e-04 | 8 | 84 | 2 | 31439548 | |
| Pubmed | Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells. | 1.60e-04 | 8 | 84 | 2 | 29323295 | |
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 20644252 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 19029121 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 16382099 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 15536084 | ||
| Pubmed | Tel2 regulates the stability of PI3K-related protein kinases. | 2.56e-04 | 10 | 84 | 2 | 18160036 | |
| Pubmed | 2.56e-04 | 10 | 84 | 2 | 10825200 | ||
| Pubmed | Real-time resolution of point mutations that cause phenovariance in mice. | 2.56e-04 | 10 | 84 | 2 | 25605905 | |
| Pubmed | 2.56e-04 | 10 | 84 | 2 | 19538885 | ||
| Pubmed | Characterization of the human patatin-like phospholipase family. | 2.56e-04 | 10 | 84 | 2 | 16799181 | |
| Pubmed | 3.13e-04 | 11 | 84 | 2 | 24349473 | ||
| Pubmed | Multivalent binding of p53 to the STAGA complex mediates coactivator recruitment after UV damage. | 3.13e-04 | 11 | 84 | 2 | 18250150 | |
| Pubmed | 3.75e-04 | 12 | 84 | 2 | 12207328 | ||
| Pubmed | Amyotrophic lateral sclerosis: an update on recent genetic insights. | 3.75e-04 | 12 | 84 | 2 | 24085347 | |
| Pubmed | Thalamocortical axons regulate neurogenesis and laminar fates in the early sensory cortex. | 3.75e-04 | 12 | 84 | 2 | 35613048 | |
| Pubmed | Molecular cloning of the mouse APS as a member of the Lnk family adaptor proteins. | 3.75e-04 | 12 | 84 | 2 | 10872802 | |
| Pubmed | 3.75e-04 | 12 | 84 | 2 | 37139782 | ||
| Pubmed | 4.42e-04 | 13 | 84 | 2 | 32266253 | ||
| Pubmed | 4.42e-04 | 13 | 84 | 2 | 23990909 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | TARDBP PPIAL4D GPATCH1 PPIAL4A ZNF512 PPIAL4G PPIA TP53 PPIAL4F | 4.96e-04 | 954 | 84 | 9 | 36373674 |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 5.82e-04 | 67 | 84 | 3 | 21875946 | |
| Pubmed | 5.93e-04 | 15 | 84 | 2 | 18418385 | ||
| Pubmed | 6.11e-04 | 159 | 84 | 4 | 31332168 | ||
| Pubmed | 7.66e-04 | 17 | 84 | 2 | 33305682 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 8.20e-04 | 1024 | 84 | 9 | 24711643 | |
| Pubmed | Novel cell lines promote the discovery of genes involved in early heart development. | 8.60e-04 | 18 | 84 | 2 | 11437454 | |
| Pubmed | Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1. | 8.60e-04 | 18 | 84 | 2 | 31257023 | |
| Pubmed | Stem cell competition driven by the Axin2-p53 axis controls brain size during murine development. | 8.60e-04 | 18 | 84 | 2 | 37054704 | |
| Pubmed | A Positive Regulatory Feedback Loop between EKLF/KLF1 and TAL1/SCL Sustaining the Erythropoiesis. | 9.60e-04 | 19 | 84 | 2 | 34360789 | |
| Pubmed | Daxx Inhibits HIV-1 Reverse Transcription and Uncoating in a SUMO-Dependent Manner. | 9.60e-04 | 19 | 84 | 2 | 32545337 | |
| Pubmed | An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. | 9.60e-04 | 19 | 84 | 2 | 16799563 | |
| Pubmed | 1.01e-03 | 650 | 84 | 7 | 38777146 | ||
| Pubmed | Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex. | 1.05e-03 | 82 | 84 | 3 | 31073041 | |
| Pubmed | 1.06e-03 | 20 | 84 | 2 | 23824729 | ||
| Pubmed | Brn-1 and Brn-2 share crucial roles in the production and positioning of mouse neocortical neurons. | 1.06e-03 | 20 | 84 | 2 | 12130536 | |
| Pubmed | Transcriptional regulation of cortical neuron migration by POU domain factors. | 1.06e-03 | 20 | 84 | 2 | 11859196 | |
| Pubmed | 1.06e-03 | 20 | 84 | 2 | 12743021 | ||
| Pubmed | 1.09e-03 | 83 | 84 | 3 | 11114734 | ||
| Pubmed | 1.17e-03 | 21 | 84 | 2 | 30111536 | ||
| Pubmed | 1.20e-03 | 86 | 84 | 3 | 26885983 | ||
| Pubmed | 1.30e-03 | 496 | 84 | 6 | 31343991 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 1.55e-03 | 701 | 84 | 7 | 30196744 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 1.59e-03 | 704 | 84 | 7 | 29955894 | |
| Pubmed | 1.67e-03 | 25 | 84 | 2 | 18564921 | ||
| Pubmed | Identification of tyrosine kinases expressed in the male mouse gubernaculum during development. | 1.67e-03 | 25 | 84 | 2 | 15254900 | |
| Pubmed | 1.80e-03 | 26 | 84 | 2 | 23988635 | ||
| Pubmed | 1.80e-03 | 26 | 84 | 2 | 25228645 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.85e-03 | 361 | 84 | 5 | 26167880 | |
| Interaction | PPIAL4G interactions | 1.07e-07 | 30 | 79 | 5 | int:PPIAL4G | |
| Cytoband | 1q21.2 | 2.15e-07 | 71 | 84 | 5 | 1q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | PPIAL4C PPIAL4E PPIAL4D PPIAL4H PDZK1P1 RORC PPIAL4G PPIAL4F | 8.17e-07 | 404 | 84 | 8 | chr1q21 |
| Cytoband | 9q22 | 5.54e-04 | 19 | 84 | 2 | 9q22 | |
| GeneFamily | Patatin like phospholipase domain containing | 4.17e-04 | 10 | 56 | 2 | 466 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 4.69e-04 | 49 | 56 | 3 | 584 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 1.40e-03 | 18 | 56 | 2 | 498 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.92e-03 | 26 | 56 | 2 | 253 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.03e-06 | 200 | 83 | 6 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-05 | 176 | 83 | 5 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 2.49e-05 | 185 | 83 | 5 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.49e-05 | 185 | 83 | 5 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 2.49e-05 | 185 | 83 | 5 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-05 | 187 | 83 | 5 | b827d9da7032bf051756ddf88352af922eb0f87b | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-05 | 187 | 83 | 5 | 61c00604dda8b36a5c3eea6554e5601aa1b884f7 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.76e-05 | 189 | 83 | 5 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 2.76e-05 | 189 | 83 | 5 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.90e-05 | 191 | 83 | 5 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.90e-05 | 191 | 83 | 5 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.90e-05 | 191 | 83 | 5 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.13e-05 | 194 | 83 | 5 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.21e-05 | 195 | 83 | 5 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-05 | 195 | 83 | 5 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.21e-05 | 195 | 83 | 5 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.21e-05 | 195 | 83 | 5 | e7f069f557a59ee7b502ff82ad4c9f47fa619ba8 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.45e-05 | 198 | 83 | 5 | e2aa1a2e5b188997e09686608cf0df55e61bd8b6 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 3.45e-05 | 198 | 83 | 5 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.53e-05 | 199 | 83 | 5 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 83 | 5 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 83 | 5 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.62e-05 | 200 | 83 | 5 | 9ae434c78e08adf95da49c85616e3ca72d1227bf | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 200 | 83 | 5 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 200 | 83 | 5 | 5abd6d81e1cc354484ae693fcd708d78926e75b5 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 200 | 83 | 5 | 9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-05 | 200 | 83 | 5 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Neuroendocrine_Carcinoma-2|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.60e-04 | 146 | 83 | 4 | bc2adef529d0bbfcccef7435401a47a6ffcc1832 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Neuroendocrine_Carcinoma|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.60e-04 | 146 | 83 | 4 | 72c1e7e0c2b6ff6c4084af61fa19c2b8eab16eda | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.78e-04 | 150 | 83 | 4 | c2c51a3230c978e2fdb1b3ae14193d4014431b25 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 154 | 83 | 4 | 1e32969bee810adaf2d560f0824a16227df513d8 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-04 | 154 | 83 | 4 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-04 | 154 | 83 | 4 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-04 | 155 | 83 | 4 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | COVID-CD4-antiviral_CD4|COVID / Condition, Cell_class and T cell subcluster | 2.02e-04 | 155 | 83 | 4 | 7e5ae034036fe85915d38a24195501e6d3bcbfb0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-04 | 155 | 83 | 4 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 2.07e-04 | 156 | 83 | 4 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 157 | 83 | 4 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-04 | 157 | 83 | 4 | bd45590da540a557dc8096980a45220fccb99505 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-04 | 157 | 83 | 4 | 00c9a58b033b8b95b0d838f233dd077b62d8b02a | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-LMPP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.27e-04 | 160 | 83 | 4 | 60fa1c717410aad7e8647703cb416cd7617cac29 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 163 | 83 | 4 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 163 | 83 | 4 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | Ciliated_cells-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.62e-04 | 166 | 83 | 4 | 4b1056aad8a99827835242b8ab0c7f2bb84471f1 | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_cell|Distal / Age, Tissue, Lineage and Cell class | 2.80e-04 | 169 | 83 | 4 | 425d89ab69e9f9eb3df84056676423e390cc6ab1 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.80e-04 | 169 | 83 | 4 | 29db25e7c5f31d98a08a35d7ec5ade203242bc50 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-OPC_related-Oligodendrocyte/OPC|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.80e-04 | 169 | 83 | 4 | b1611e61f635f8f9b87250e026ad30999cbee041 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.6.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.87e-04 | 170 | 83 | 4 | e0429f45a3639a10294ceb492f2286c495481c2b | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 3.00e-04 | 172 | 83 | 4 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.00e-04 | 172 | 83 | 4 | 2651dece87c3e3d2d6370f5274ebae357474b825 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_ciliated|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.13e-04 | 174 | 83 | 4 | b8d1c556290d188f56aeefc17f03119686945fe7 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-MAIT|Int-URO / Disease, Lineage and Cell Type | 3.13e-04 | 174 | 83 | 4 | 5227ed29f5f0d3e0aaa7f3cfd362f96d3e2660f7 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.13e-04 | 174 | 83 | 4 | 00cf27bc23af1472a507be31fba6245a8fdd901b | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_ciliated|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.20e-04 | 175 | 83 | 4 | b1369d2b74f461e6822d0c33e9b50fe0dfbceb54 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.20e-04 | 175 | 83 | 4 | 9d09636a103daa8f622c3dbfd1f1536aaec3b6bb | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.20e-04 | 175 | 83 | 4 | c82ec6deb6ccdd991a69a62b6d62d5b14c803d7a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-04 | 177 | 83 | 4 | 164ffbbf798defa3728197deb1a14b661490e525 | |
| ToppCell | LPS-antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.41e-04 | 178 | 83 | 4 | 289d1425c4e57fabcca994b27f9af1c0ce5d5bec | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.41e-04 | 178 | 83 | 4 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-04 | 178 | 83 | 4 | f52f837e948deb6a2d031325f49891bca8d375da | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-04 | 180 | 83 | 4 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.63e-04 | 181 | 83 | 4 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.63e-04 | 181 | 83 | 4 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.71e-04 | 182 | 83 | 4 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 3.71e-04 | 182 | 83 | 4 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | mild-B_cell|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.79e-04 | 183 | 83 | 4 | 175aaf8fbbff52eab87d78a49d5ab02cd489c438 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.87e-04 | 184 | 83 | 4 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.87e-04 | 184 | 83 | 4 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.95e-04 | 185 | 83 | 4 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.95e-04 | 185 | 83 | 4 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 3.95e-04 | 185 | 83 | 4 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.95e-04 | 185 | 83 | 4 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | 18-Distal-Epithelial-Multiciliated_cell|Distal / Age, Tissue, Lineage and Cell class | 4.11e-04 | 187 | 83 | 4 | 8d7fa6b2950898e7f283401808378ba2a41b9651 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.11e-04 | 187 | 83 | 4 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 4.19e-04 | 188 | 83 | 4 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.19e-04 | 188 | 83 | 4 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.19e-04 | 188 | 83 | 4 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.28e-04 | 189 | 83 | 4 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 4.28e-04 | 189 | 83 | 4 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 4.28e-04 | 189 | 83 | 4 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | 4.28e-04 | 189 | 83 | 4 | 711181ca3b9102fb155168b646b0a9b09ff215b2 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.36e-04 | 190 | 83 | 4 | a90a38fccdbf75a286b4d258fc54920c02b282f7 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.36e-04 | 190 | 83 | 4 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.45e-04 | 191 | 83 | 4 | dad675251e129254955eac179c84a641a4864586 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.45e-04 | 191 | 83 | 4 | 6d2cf41ee946137c039ddcc13593fc3f670afbba | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 4.45e-04 | 191 | 83 | 4 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.45e-04 | 191 | 83 | 4 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|normal_Lung / Location, Cell class and cell subclass | 4.54e-04 | 192 | 83 | 4 | 097a13121820ab4e5cd2365600efccf5ea4ce8c3 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.54e-04 | 192 | 83 | 4 | 03acd4a26b986e34eee608747347791122f1aa52 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-ciliated_cell-Epi-Ciliated|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.54e-04 | 192 | 83 | 4 | 31c6046589e2fbb0486fd044c5b128099d37872f | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 4.54e-04 | 192 | 83 | 4 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 4.54e-04 | 192 | 83 | 4 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 4.54e-04 | 192 | 83 | 4 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.63e-04 | 193 | 83 | 4 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.63e-04 | 193 | 83 | 4 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.63e-04 | 193 | 83 | 4 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.63e-04 | 193 | 83 | 4 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.63e-04 | 193 | 83 | 4 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.63e-04 | 193 | 83 | 4 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.72e-04 | 194 | 83 | 4 | b0477583301dc6d9767b667bd2f8f94fbfaa6f81 | |
| Disease | disease of cellular proliferation (implicated_via_orthology) | 5.05e-07 | 7 | 73 | 3 | DOID:14566 (implicated_via_orthology) | |
| Disease | Keratosis Blennorrhagica | 6.01e-05 | 5 | 73 | 2 | C0022594 | |
| Disease | Keratosis | 6.01e-05 | 5 | 73 | 2 | C0022593 | |
| Disease | Keratoma | 6.01e-05 | 5 | 73 | 2 | C0086501 | |
| Disease | tongue squamous cell carcinoma (biomarker_via_orthology) | 9.00e-05 | 6 | 73 | 2 | DOID:0050865 (biomarker_via_orthology) | |
| Disease | hoarding disorder | 9.78e-05 | 36 | 73 | 3 | EFO_0803361 | |
| Disease | sarcoma (is_implicated_in) | 1.67e-04 | 8 | 73 | 2 | DOID:1115 (is_implicated_in) | |
| Disease | Gastric Adenocarcinoma | 1.91e-04 | 45 | 73 | 3 | C0278701 | |
| Disease | glioblastoma multiforme | 2.15e-04 | 9 | 73 | 2 | EFO_0000519 | |
| Disease | pterygium (is_marker_for) | 2.15e-04 | 9 | 73 | 2 | DOID:0002116 (is_marker_for) | |
| Disease | melanoma | 3.80e-04 | 248 | 73 | 5 | C0025202 | |
| Disease | Psoriasis | 3.86e-04 | 57 | 73 | 3 | C0033860 | |
| Disease | Pustulosis of Palms and Soles | 3.86e-04 | 57 | 73 | 3 | C0030246 | |
| Disease | B-Cell Lymphomas | 3.92e-04 | 12 | 73 | 2 | C0079731 | |
| Disease | Amyotrophic Lateral Sclerosis | 4.07e-04 | 58 | 73 | 3 | C0002736 | |
| Disease | hematologic cancer (implicated_via_orthology) | 4.63e-04 | 13 | 73 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | cirrhosis of liver | 4.63e-04 | 13 | 73 | 2 | EFO_0001422 | |
| Disease | neutrophil count | DNAJC13 PPIAL4D TTC39C RTCA GSDMB PNPLA3 LRBA DPP8 MAP4K4 TENT5B FANCA | 5.63e-04 | 1382 | 73 | 11 | EFO_0004833 |
| Disease | Non-Small Cell Lung Carcinoma | 6.16e-04 | 156 | 73 | 4 | C0007131 | |
| Disease | epilepsy (implicated_via_orthology) | 7.26e-04 | 163 | 73 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Amyotrophic lateral sclerosis | 8.02e-04 | 17 | 73 | 2 | cv:C0002736 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 9.00e-04 | 18 | 73 | 2 | EFO_1000649, HP_0000131 | |
| Disease | essential hypertension (is_implicated_in) | 9.00e-04 | 18 | 73 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | skin sensitivity to sun | 1.00e-03 | 19 | 73 | 2 | EFO_0004795 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 1.07e-03 | 181 | 73 | 4 | DOID:684 (is_implicated_in) | |
| Disease | Hodgkins lymphoma | 1.12e-03 | 82 | 73 | 3 | EFO_0000183 | |
| Disease | Malignant neoplasm of breast | 1.30e-03 | 1074 | 73 | 9 | C0006142 | |
| Disease | cholelithiasis | 1.37e-03 | 88 | 73 | 3 | EFO_0004799 | |
| Disease | nevus count, cutaneous melanoma | 1.51e-03 | 91 | 73 | 3 | EFO_0000389, EFO_0004632 | |
| Disease | Adenocarcinoma of large intestine | 1.76e-03 | 96 | 73 | 3 | C1319315 | |
| Disease | triacylglycerol 48:0 measurement | 1.89e-03 | 26 | 73 | 2 | EFO_0010403 | |
| Disease | coronary artery disease (is_implicated_in) | 1.98e-03 | 100 | 73 | 3 | DOID:3393 (is_implicated_in) | |
| Disease | Neoplasm Metastasis | 2.08e-03 | 217 | 73 | 4 | C0027627 | |
| Disease | Seizures | 2.12e-03 | 218 | 73 | 4 | C0036572 | |
| Disease | Amyotrophic Lateral Sclerosis With Dementia | 2.35e-03 | 29 | 73 | 2 | C0393554 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGGKRGYFGFVCVER | 376 | Q5RHP9 | |
| ERVVHAKGAGAFGYF | 71 | P04040 | |
| GEKRTFFGCRHYTTG | 41 | Q8TAX9 | |
| FGVFGKHCELNSYGF | 3966 | Q6V0I7 | |
| RVFLSYCSLHGAQGG | 2156 | Q8TDJ6 | |
| GHYKFCELLIGRGAH | 1331 | O75179 | |
| FYGCGFRHLVGDSLI | 481 | Q9BYV7 | |
| ALGFVFHKGSYLRNG | 151 | Q00975 | |
| GRVAGCSVHKGYAFV | 46 | Q9UKM9 | |
| NLGHGSFTKIYRGCR | 526 | P52333 | |
| GKIFTFGSYRLGVHT | 96 | Q9NRJ5 | |
| TGEKGFRYKGSCFHR | 41 | A0A0B4J2A2 | |
| QGFYCGVGLFTRFLK | 311 | Q6Y2X3 | |
| GQRLKVIYGSCAGFH | 1081 | O95819 | |
| NYLGGFALSVAHGRK | 46 | P43405 | |
| CLTVRARGHSYFAGF | 756 | Q6ZU64 | |
| GRRFHGKAVEGKGCY | 356 | O14498 | |
| DEKGRYKRFHGAFSG | 41 | Q9BRR8 | |
| ILDHLGSGAFGCVYK | 521 | Q6ZWH5 | |
| GVSKLHGCLYVVGGF | 501 | Q9P2G9 | |
| CFRGEGSHGVILFLY | 251 | A8MYZ0 | |
| PRLCYLVKEGGSHGF | 11 | A8MUH7 | |
| LCRLAKGENGYGFHL | 261 | A8MUH7 | |
| GFLGFYHVGATRCLS | 16 | Q9NST1 | |
| LSFAACGFLGIYHLG | 6 | P41247 | |
| HGYGIRLLGFDKQCS | 491 | Q5QP82 | |
| KGLGYSAHFVGGCLI | 261 | P50851 | |
| ALASKGGTGRCYFHG | 651 | A0A1B0GTW7 | |
| RALGAKKFYGRFCTG | 136 | Q8TDZ2 | |
| LYRIMGNGFAGCVHF | 486 | Q71SY5 | |
| IGFCRENGFHGLVAY | 171 | Q9NZB2 | |
| SYGFRLGFLHSGTAK | 106 | P04637 | |
| TGEKGFRYKGSCFHR | 41 | P0DN26 | |
| LFHYCVGSGLAGREL | 61 | Q7Z7J7 | |
| TGEKGFRYKGSCFHR | 41 | A0A075B759 | |
| AKGGSFYRDHCPVLG | 221 | Q86YT6 | |
| FTLCRKLGSGYFGEV | 191 | Q13882 | |
| TGEKGFRYKGSCFHR | 41 | F5H284 | |
| TGEKGFRYKGSCFHR | 41 | A0A075B767 | |
| IHGAVFGKGTYFARD | 226 | Q9NR21 | |
| ACIYTRKGVFFAGGT | 46 | Q8IUM7 | |
| IFTFGSYRLGVHTKG | 96 | Q9BWT3 | |
| TGEKGFRYKGSCFHR | 41 | Q9Y536 | |
| TGEKGFRYKGSCFHR | 41 | P0DN37 | |
| RAGFNASFHKSCGGY | 2081 | O60494 | |
| FGFKFSYRIISCGGV | 3026 | O60494 | |
| LGRVAFFVGGYCVSK | 166 | O14756 | |
| FGYVCGKEGNHRFVA | 126 | O75553 | |
| HSGGVFYLCGTFRNL | 361 | Q8NCQ5 | |
| IHGFCGQSKLLIYGR | 251 | Q92562 | |
| FGSTRGYHGCSKKAL | 456 | O15360 | |
| GILGVQLFKGKFYHC | 1321 | Q9P0X4 | |
| GTFLFQAGSGIYHVK | 176 | Q6V1X1 | |
| GSCHRGLKFEGAFKY | 706 | Q6V1X1 | |
| HGFVLVSFGAGVKYL | 286 | Q16880 | |
| QGGFCILYGGFSRLH | 166 | O75165 | |
| TFRHYRVLGKGGFGE | 186 | P32298 | |
| KVGRFGIGFNSVYHI | 186 | Q9NZJ4 | |
| AGHIFLGFSKCGRYV | 76 | Q66K64 | |
| DGKLYVCGGFHGADR | 551 | Q3ZCT8 | |
| YKGFLGCFPDIIGTH | 496 | Q9Y5X1 | |
| TGGLLIACAHFGAYV | 226 | Q7Z4G4 | |
| TGEKGFGYKGSCFHR | 41 | P62937 | |
| TGHSKGFGFVRFTEY | 141 | Q13148 | |
| AGGKYKAFSICGSHL | 231 | Q8NG95 | |
| GSTVKYSCVGGFFLR | 2401 | Q4LDE5 | |
| GGGLLKYCHLLVRGF | 276 | Q96A09 | |
| HLLGRGGFSEVYKAF | 466 | Q86UE8 | |
| YCVLLTFGFGALSKH | 421 | Q5T4D3 | |
| IHYGVITCEGCKGFF | 41 | P51449 | |
| FGGYGRSCLHIKRDK | 111 | Q9BSK1 | |
| RGCVTKIYGRAFVAG | 186 | O00442 | |
| TRCGGKLGFLASYFL | 726 | Q12772 | |
| IHYGVITCEGCKGFF | 31 | Q92753 | |
| ILGKGFFAAYEATCG | 451 | Q9Y6L7 | |
| GGSARFHCATGYQLK | 376 | Q53EL9 | |
| GRFHYGTAFGGSKVK | 956 | Q9NW08 | |
| ECGKGFRYGSGLLSH | 716 | Q9UJW7 | |
| QCGKGFSRRSGLYVH | 236 | Q9UK10 | |
| EHLIYAFFGIVIGCG | 311 | Q5TAH2 | |
| AFFGIVIGCGELSHY | 316 | Q5TAH2 | |
| KGAVSFGYGLFHLCI | 216 | Q8N584 | |
| LFSVIIHKGGCYGGH | 291 | Q9NVE5 | |
| HLGSCTLGNFVAGKY | 426 | Q96ME7 | |
| SISHVAYRVLGKFGG | 886 | Q9Y4A5 | |
| FGHFKFCITLFGGYV | 256 | Q7Z769 | |
| RDLGEGHFGKVSLYC | 901 | P29597 | |
| VVFALGFLGCYGAKT | 66 | O60635 | |
| GCKFLLYAHRVGRGV | 161 | Q8NFZ6 |